News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LaPlume Joseph W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 700 shares
@ $216.52, valued at
$151.6k
|
|
| 05/31/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 2,189 shares
@ $0
Paid exercise price by delivering 184 shares
@ $194.12, valued at
$35.7k
Paid exercise price by delivering 125 shares
@ $194.12, valued at
$24.3k
Paid exercise price by delivering 223 shares
@ $194.12, valued at
$43.3k
Granted 5,252 options to buy
@ $194.12, valued at
$1M
|
|
| 05/15/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 950 shares
@ $193.02, valued at
$183.4k
Sold 9 shares
@ $194.07, valued at
$1.7k
|
|
| 02/22/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Paid exercise price by delivering 317 shares
@ $243.6, valued at
$77.2k
|
|
| 01/30/2023 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 8,676 shares
@ $0
Paid exercise price by delivering 3,261 shares
@ $244.29, valued at
$796.6k
|
|
| 12/05/2022 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 1,138 shares
@ $223.055, valued at
$253.8k
Sold 4,165 shares
@ $224.4139, valued at
$934.7k
Sold 1,106 shares
@ $224.8502, valued at
$248.7k
Exercised 6,409 options to buy
@ $109.34, valued at
$700.8k
|
|
| 11/07/2022 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 534 shares
@ $216.36, valued at
$115.5k
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 11,344 shares
@ $0
Paid exercise price by delivering 4,570 shares
@ $312.24, valued at
$1.4M
|
|
| 12/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/05/2020 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Gifted 285 shares
@ $0
Sold 2,639 shares
@ $249.0907, valued at
$657.4k
Sold 580 shares
@ $250.229, valued at
$145.1k
Sold 3,520 shares
@ $251.1773, valued at
$884.1k
Exercised 492 options to buy
@ $88.05, valued at
$43.3k
Exercised 3,205 options to buy
@ $109.34, valued at
$350.4k
Exercised 3,042 options to buy
@ $144.67, valued at
$440.1k
|
|
| 06/02/2020 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Granted 2,004 shares
@ $0
Granted 6,685 options to buy
@ $179.66, valued at
$1.2M
|
|
| 05/19/2020 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL, INC.|
Txns:
| Sold 10,519 shares
@ $167.9977, valued at
$1.8M
Sold 4,899 shares
@ $168.8104, valued at
$827k
Sold 350 shares
@ $174.6511, valued at
$61.1k
Exercised 3,350 options to buy
@ $73.7, valued at
$246.9k
Exercised 3,000 options to buy
@ $88.05, valued at
$264.2k
|
|
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2019 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC|
Txns:
| Sold 200 shares
@ $138.18, valued at
$27.6k
Sold 30 shares
@ $138.19, valued at
$4.1k
Sold 3 shares
@ $138.195, valued at
$414.6
Sold 300 shares
@ $138.2, valued at
$41.5k
Sold 30 shares
@ $138.205, valued at
$4.1k
Sold 300 shares
@ $138.22, valued at
$41.5k
Sold 300 shares
@ $138.23, valued at
$41.5k
Sold 100 shares
@ $138.24, valued at
$13.8k
Sold 100 shares
@ $138.26, valued at
$13.8k
Sold 200 shares
@ $138.28, valued at
$27.7k
Sold 3 shares
@ $138.3, valued at
$414.9 |
|
| 03/12/2019 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC|
Txns:
| Sold 200 shares
@ $137.835, valued at
$27.6k
Sold 200 shares
@ $137.85, valued at
$27.6k
Sold 99 shares
@ $137.86, valued at
$13.6k
Sold 300 shares
@ $137.87, valued at
$41.4k
Sold 100 shares
@ $137.88, valued at
$13.8k
Sold 100 shares
@ $137.89, valued at
$13.8k
Sold 300 shares
@ $137.9, valued at
$41.4k
Sold 299 shares
@ $137.91, valued at
$41.2k
Sold 200 shares
@ $137.92, valued at
$27.6k
Sold 195 shares
@ $137.97, valued at
$26.9k
Sold 100 shares
@ $137.98, valued at
$13.8k
|
|
| 03/12/2019 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC|
Txns:
| Sold 200 shares
@ $137.415, valued at
$27.5k
Sold 100 shares
@ $137.43, valued at
$13.7k
Sold 198 shares
@ $137.44, valued at
$27.2k
Sold 302 shares
@ $137.45, valued at
$41.5k
Sold 400 shares
@ $137.46, valued at
$55k
Sold 400 shares
@ $137.48, valued at
$55k
Sold 100 shares
@ $137.495, valued at
$13.7k
Sold 200 shares
@ $137.515, valued at
$27.5k
Sold 308 shares
@ $137.53, valued at
$42.4k
Sold 300 shares
@ $137.56, valued at
$41.3k
Sold 100 shares
@ $137.58, valued at
$13.8k
|
|
| 02/28/2019 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC|
Txns:
| Paid exercise price by delivering 304 shares
@ $145.31, valued at
$44.2k
Paid exercise price by delivering 156 shares
@ $140.71, valued at
$22k
|
|
| 02/26/2019 |
4
| LaPlume Joseph W (EVP, Corp Strategy & Develop) has filed a Form 4 on CHARLES RIVER LABORATORIES INTERNATIONAL INC|
Txns:
| Granted 2,854 shares
@ $0
Paid exercise price by delivering 316 shares
@ $144.67, valued at
$45.7k
Paid exercise price by delivering 322 shares
@ $144.67, valued at
$46.6k
Granted 12,170 options to buy
@ $144.67, valued at
$1.8M
|
|
|
|